The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management
Completed
- Conditions
- Pain
- Interventions
- Behavioral: No intervention
- First Posted Date
- 2013-04-11
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 587
- Registration Number
- NCT01829828
A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2015-01-01
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1065
- Registration Number
- NCT01819805
A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 3267
- Registration Number
- NCT01819818
Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 636
- Registration Number
- NCT01816503
A Study Comparing the Effectiveness and Safety of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen With Immediate Release (IR) Tramadol HCl/Acetaminophen in Participants With Moderate to Severe Postoperative Pain
Phase 3
Completed
- Conditions
- Pain, Postoperative
- Interventions
- First Posted Date
- 2013-03-20
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 320
- Registration Number
- NCT01814878
A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction
- First Posted Date
- 2013-03-01
- Last Posted Date
- 2017-06-22
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 379
- Registration Number
- NCT01802359
A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 56
- Registration Number
- NCT01778075
A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista
- First Posted Date
- 2012-12-05
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 225
- Registration Number
- NCT01741831
A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence
- First Posted Date
- 2012-12-05
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 57
- Registration Number
- NCT01741844
A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease
- First Posted Date
- 2012-11-27
- Last Posted Date
- 2013-08-05
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1882
- Registration Number
- NCT01734395
© Copyright 2025. All Rights Reserved by MedPath